Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Sabra Healthcare REIT Inc (NASDAQ: SBRA) closed at $18.12 up 0.28% from its previous closing price of $18.07. In other words, the price has increased by $0.28 from its previous closing price. On the day, 2.43 million shares were traded. SBRA stock price reached its highest trading level at $18.265 during the session, while it also had its lowest trading level at $18.055.
Ratios:
For a deeper understanding of Sabra Healthcare REIT Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 149.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.76. For the most recent quarter (mrq), Quick Ratio is recorded 0.25 and its Current Ratio is at 0.25. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.89.
On January 07, 2025, JMP Securities Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $20.
Mizuho Downgraded its Outperform to Neutral on December 05, 2024, while the target price for the stock was maintained at $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 20 ’25 when FOSTER MICHAEL J sold 11,000 shares for $18.22 per share. The transaction valued at 200,376 led to the insider holds 64,725 shares of the business.
Michael J. Foster bought 11,000 shares of SBRA for $192,500 on May 15 ’25. On Feb 24 ’25, another insider, Cusack Catherine, who serves as the Director of the company, bought 1,500 shares for $15.92 each. As a result, the insider paid 23,880 and bolstered with 60,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 4311400448 and an Enterprise Value of 6751601152. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.67, and their Forward P/E ratio for the next fiscal year is 23.56. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.04 while its Price-to-Book (P/B) ratio in mrq is 1.60. Its current Enterprise Value per Revenue stands at 9.374 whereas that against EBITDA is 15.627.
Stock Price History:
The Beta on a monthly basis for SBRA is 0.82, which has changed by 0.09184289 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, SBRA has reached a high of $19.99, while it has fallen to a 52-week low of $15.60. The 50-Day Moving Average of the stock is 0.44%, while the 200-Day Moving Average is calculated to be 2.47%.
Shares Statistics:
For the past three months, SBRA has traded an average of 2.55M shares per day and 2495680 over the past ten days. A total of 237.94M shares are outstanding, with a floating share count of 233.52M. Insiders hold about 1.86% of the company’s shares, while institutions hold 97.69% stake in the company. Shares short for SBRA as of 1749772800 were 19510458 with a Short Ratio of 7.81, compared to 1747267200 on 20538670. Therefore, it implies a Short% of Shares Outstanding of 19510458 and a Short% of Float of 11.58.
Dividends & Splits
According to the company, the forward annual dividend rate for SBRA is 1.13, from 1.2 in the trailing year. Against a Trailing Annual Dividend Yield of 0.06640842The stock’s 5-year Average Dividend Yield is 8.37. The current Payout Ratio is 223.55% for SBRA, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-05-16. Stock splits for the company last occurred on 2010-11-16 when the company split stock in a 1:3 ratio.
Earnings Estimates
Its stock is currently analyzed by 2.0 different market analysts. The consensus estimate for the next quarter is $0.17, with high estimates of $0.18 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.7 and $0.68 for the fiscal current year, implying an average EPS of $0.69. EPS for the following year is $0.75, with 2.0 analysts recommending between $0.76 and $0.74.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $186.27M this quarter.It ranges from a high estimate of $188.31M to a low estimate of $185.2M. As of the current estimate, Sabra Healthcare REIT Inc’s year-ago sales were $176.14MFor the next quarter, 4 analysts are estimating revenue of $192.03M. There is a high estimate of $198.44M for the next quarter, whereas the lowest estimate is $188.1M.
A total of 4 analysts have provided revenue estimates for SBRA’s current fiscal year. The highest revenue estimate was $781.91M, while the lowest revenue estimate was $747.3M, resulting in an average revenue estimate of $758.97M. In the same quarter a year ago, actual revenue was $703.24MBased on 6 analysts’ estimates, the company’s revenue will be $801.67M in the next fiscal year. The high estimate is $945.41M and the low estimate is $739.29M.
